
The All India Institute of Medical Sciences in New Delhi on Monday started the screening for clinical trials of Covaxin, India’s indigenously developed Covid-19 vaccine, in children. Nearly 20 to 30 teens aged between 12 and 18 years participated in it.
from Delhi News: Latest Delhi News Headlines & Live Updates from Delhi - Times of India https://ift.tt/3iqLQIi
via
IFTTT
No comments